雜志介紹

Science Translational Medicine雜志介紹

《Science Translational Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱科學轉化醫學，本刊主要出版、報道醫學-CELL BIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為15.8，最新CiteScore 指數為26.7。

本刊近期中國學者發表的論文主要有：

• Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice

  Author: Zhao, Yongliang; Ni, Wenjia; Liang, Simeng; Dong, Lianghui; Xiang, Min; Cai, Zeng; Niu, Danping; Zhang, Qiuhan; Wang, Dehe; Zheng, Yucheng; Zhang, Zhen; Zhou, Dan; Guo, Wenhua; Pan, Yongbing; Wu, Xiaoli; Yang, Yimin; Jing, Zhaofei; Jiang, Yongzhong; Chen, Yu; Yan, Huan; Zhou, Yu; Xu, Ke; Lan, Ke

• Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models

  Author: Su, Liangping; Chen, Yitian; Huang, Cheng; Wu, Sangqing; Wang, XiaoJuan; Zhao, Xinbao; Xu, Qiuping; Sun, Ruipu; Kong, Xiangzhan; Jiang, Xue; Qiu, Xiaoyi; Huang, Xiaoming; Wang, Minghui; Wong, Ping-Pui

• CD200+cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy

  Author: Wang, Xinxin; Zha, Haoran; Wu, Wei; Yuan, Ting; Xie, Shuanglong; Jin, Zheng; Long, Haixia; Yang, Fei; Wang, Zhongyu; Zhang, Anmei; Gao, Jianbao; Jiang, Ying; Wang, Lujing; Hu, Chunyan; Wan, Yisong Y.; Li, Qi-Jing; Symonds, Alistair L. J.; Jia, Qingzhu; Zhu, Bo

• Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells

  Author: Lv, Jiadi; Zhou, Yabo; Zhou, Nannan; Wang, Zhenfeng; Chen, Jie; Chen, Haoran; Wang, Dianheng; Zhou, Li; Wei, Keke; Zhang, Huafeng; Tang, Ke; Ma, Jingwei; Liu, Yuying; Wan, Yonghong; Zhang, Yi; Zhang, Haizeng; Huang, Bo

英文介紹

Science Translational Medicine雜志英文介紹

Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.